Is Trending Stock MercadoLibre, Inc. (MELI) a Buy Now?

MercadoLibre is rated Zacks Rank #4 (Sell), with consensus EPS estimates declining 0.6% for the current quarter, 2.6% for the current fiscal year, and 1.5% for next fiscal year over the past month. Zacks sees possible near-term underperformance despite strong projected sales growth: current-quarter revenue is estimated at $10.66B, up 43.8% year over year, while its latest reported quarter beat revenue and EPS estimates by 4.07% and 5.75%, respectively. Shares fell 3.2% over the past month, versus a 0.9% gain for the S&P 500; valuation was graded in line with peers.

Analysis

The key signal is not the headline growth rate but the divergence between rapid forecast sales growth and weakening EPS expectations. That points to a potential conversion problem: if growth requires heavier fulfillment, customer incentives, or payments/credit investment, incremental revenue may not be translating into near-term earnings. Those are hypotheses to test in segment margins, operating expenses, and credit-loss disclosures—not conclusions established by this article.

The estimate curve is also being pushed out: current-year EPS is expected to decline, while next-year growth remains substantial but its consensus has recently been cut. That makes the equity unusually dependent on the projected rebound arriving on schedule. Persistent revisions downward could compress the growth multiple even with strong reported sales; stabilization in estimates and margin improvement would challenge the cautious case. The recent relative weakness may already reflect some of this risk, so the article alone does not justify an outright short.

Over the next 1–3 months, focus on the next results and revisions to operating profitability, credit quality, and guidance—not revenue beats in isolation. Over 6–18 months, sustained monetization and operating leverage could restore earnings momentum; conversely, intensifying investment or weaker consumer/credit conditions could prolong the earnings lag. The article supplies no valuation multiples, margin bridge, or options pricing, so sizing a directional or options trade from it alone is not warranted.

Key Decisions for Investors

• Keep MELI at neutral-to-underweight versus a broad equity or e-commerce benchmark until EPS revisions stabilize; avoid treating strong sales growth alone as confirmation of the earnings rebound.
• Use the next earnings release as the decision point: upgrade the stance if operating margins and credit metrics improve alongside revenue and forward EPS estimates stop falling; reduce further if profitability weakens or guidance/revisions deteriorate.
• Do not initiate an outright short solely on the Zacks rating and recent estimate cuts. If positioning requires a bearish expression, first verify valuation, upcoming catalyst timing, and option-implied volatility; consider a defined-risk structure only if those inputs offer acceptable risk/reward.
• Falsification watch: sustained upward revisions to forward EPS accompanied by demonstrable operating leverage would invalidate the cautious thesis; continued EPS cuts despite revenue growth would strengthen it.